Evidence map›Paper›PMID 27428882›Full record

ReviewArthritis & rheumatology (Hoboken, N.J.)2016

Review: Novel Insights Into Tumor Necrosis Factor Receptor, Death Receptor 3, and Progranulin Pathways in Arthritis and Bone Remodeling.

Anwen Williams, Eddie C Y Wang, Lorenz Thurner, Chuan-Ju Liu

Open access · hybridAbstract readReview
In one paragraph

Review in Arthritis & rheumatology (Hoboken, N.J.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Targeting tumor necrosis factor receptors in ankylosing spondylitis.Annals of the New York Academy of Sciences · 2019
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

Anwen WilliamsCardiff University, Cardiff, UK.
Eddie C Y WangCardiff University, Cardiff, UK.
Lorenz ThurnerSaarland University Medical School, Homburg, Saar, Germany.
Chuan-Ju LiuNew York University Medical Center, New York, New York.
Cardiff University · GBColumbia University Irving Medical Center · USSaarland University · DE

Funding

The immunological mechanism of PGRNs anti-inflammatory effect - Renewal - 1R01AR062207 · NIAMS · YALE UNIVERSITY · PI Chuanju Liu · 2012 to 2026
$5.6M
The Role of PGRN Growth Factor in Osteoarthritis. - Renewal - 1 - Revision - 2R01AR061484 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI LIU, CHUANJU · 2011 to 2020
$4.8M
Medical Research Council G0901119NIAMS NIH HHS R01 AR061484NIAMS NIH HHS R01 AR062207
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ArthritisBone RemodelingHumansIntercellular Signaling Peptides and ProteinsProgranulinsReceptors, Tumor Necrosis FactorReceptors, Tumor Necrosis Factor, Member 25Signal TransductionGRN protein, humanIntercellular Signaling Peptides and ProteinsProgranulinsReceptors, Tumor Necrosis FactorReceptors, Tumor Necrosis Factor, Member 25

Identifiers

PMID27428882
PMCPMC5599977
OpenAlexW2559474164

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.